Spontaneous Activity of CB2 Receptors Attenuates Stress-Induced Behavioral and Neuroplastic Deficits in Male Mice

被引:8
|
作者
Ribeiro, Melissa A. [1 ]
Aguiar, Rafael P. [2 ]
Scarante, Franciele F. [2 ]
Fusse, Eduardo J. [3 ]
de Oliveira, Rubia M. W. [2 ]
Guimaraes, Francisco S. [1 ]
Campos, Alline C. [4 ]
机构
[1] Univ Estadual Maringa, Dept Pharmacol & Therapeut, Maringa, Parana, Brazil
[2] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Sao Paulo, Brazil
[3] Univ Sao Paulo, Ribeirao Preto Med Sch, Mental Hlth Grad Program, Sao Paulo, Brazil
[4] Univ Sao Paulo, Pharmacol, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
chronic stress; CB2 inverse agonist; escitalopram; hippocampus; neuroplasticity; HIPPOCAMPAL NEUROGENESIS; CANNABINOID RECEPTOR; ENDOCANNABINOID SYSTEM; CELL-PROLIFERATION; INDUCED ACTIVATION; DENTATE GYRUS; DEPRESSION; EXPRESSION; INVOLVEMENT; INHIBITION;
D O I
10.3389/fphar.2021.805758
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The monoaminergic theory of depression/anxiety disorders cannot fully explain the behavioral and neuroplastic changes observed after ADs chronic treatment. Endocannabinoid system, which comprises CB2 receptors, has been associated with the chronic effects of these drugs, especially in stressed mice. CB2-KO mice display more vulnerability to stressful stimuli. In the present study, we hypothesized that the behavioral and neuroplastic effects observed after repeated treatment with the AD escitalopram (Esc) in chronically stressed mice depend on CB2 receptor signaling. Male mice submitted to chronic unpredictable stress (CUS) paradigm (21 days) were treated daily with AM630 (0.01; 0.03 or 0.3 mg/kg, i.p) a CB2 receptor antagonist/inverse agonist. At e 19th day of the CUS protocol, mice were submitted to Open field test and Tail-suspension test to evaluate antidepressant-like behavior. At the end of the stress protocol, mice were submitted to Novel Suppressed Feeding test (day 22nd) to evaluate anxiety-like behavior. In a second series of experiments, male mice treated with Esc (10 mg/kg, daily, 21 days) in the presence or not of AM630 (0.30 mg/kg) were submitted to the same round of behavioral tests in the same conditions as performed in the dose-response curve protocol. Animals were then euthanized under deep anesthesia, and their brains/hippocampi removed for immunohistochemistry (Doublecortin-DCX) or Western Blot assay. Our results demonstrated that chronic treatment with AM630, a CB2 antagonist/inverse agonist, induces anxiolytic-like effects in stressed mice. Moreover, chronic reduction of CB2 receptor endogenous activity by AM630 attenuated the neuroplastic (potentiating stress-induced decreased expression of pro-BDNF, but enhanced pmTOR and DAGL expression in the hippocampus reduced in stressed mice), the antidepressant- but not the anxiolytic-like effects of Esc. AM630 alone or in combination with Esc decreased the expression of DCX + cell in both the subgranular and granular layers of the dentate gyrus (DG), indicating a general reduction of DCX + neuroblasts and a decrease in their migration through the DG layers. We suggest that the antidepressant-like behavior and the pro-neurogenic effect, but not the anxiolytic like behavior, promoted by Esc in stressed mice are, at least in part, mediated by CB2 receptors.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Role of CB2 receptors in social and aggressive behavior in male mice
    Rodriguez-Arias, Marta
    Navarrete, Francisco
    Carmen Blanco-Gandia, M.
    Carmen Arenas, M.
    Aguilar, Maria A.
    Bartoll-Andres, Adrian
    Valverde, Olga
    Minarro, Jose
    Manzanares, Jorge
    PSYCHOPHARMACOLOGY, 2015, 232 (16) : 3019 - 3031
  • [2] Role of CB2 receptors in social and aggressive behavior in male mice
    Marta Rodríguez-Arias
    Francisco Navarrete
    M. Carmen Blanco-Gandia
    M. Carmen Arenas
    María A. Aguilar
    Adrián Bartoll-Andrés
    Olga Valverde
    José Miñarro
    Jorge Manzanares
    Psychopharmacology, 2015, 232 : 3019 - 3031
  • [3] Flupirtine attenuates chronic restraint stress-induced cognitive deficits and hippocampal apoptosis in male mice
    Huang, Pengcheng
    Li, Cai
    Fu, Tianli
    Zhao, Dan
    Yi, Zhen
    Lu, Qing
    Guo, Lianjun
    Xu, Xulin
    BEHAVIOURAL BRAIN RESEARCH, 2015, 288 : 1 - 10
  • [4] Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors
    Aghaei, Iraj
    Rostampour, Mohammad
    Shabani, Mohammad
    Naderi, Nima
    Motamedi, Fereshteh
    Babaei, Parvin
    Khakpour-Taleghani, Behrooz
    EPILEPSY RESEARCH, 2015, 117 : 23 - 28
  • [5] The roles of cannabinoid CB1 and CB2 receptors in cocaine-induced behavioral sensitization and conditioned place preference in mice
    Lopes, Jadna B.
    Bastos, Juliana R.
    Costa, Rayssa B.
    Aguiar, Daniele C.
    Moreira, Fabricio A.
    PSYCHOPHARMACOLOGY, 2020, 237 (02) : 385 - 394
  • [6] The roles of cannabinoid CB1 and CB2 receptors in cocaine-induced behavioral sensitization and conditioned place preference in mice
    Jadna B. Lopes
    Juliana R. Bastos
    Rayssa B. Costa
    Daniele C. Aguiar
    Fabrício A. Moreira
    Psychopharmacology, 2020, 237 : 385 - 394
  • [7] Attenuation of Restraint Stress-Induced Behavioral Deficits by Environmental Enrichment in Male Rats
    Nawaz, Amber
    Batool, Zehra
    Ahmed, Saara
    Khaliq, Saima
    Sajid, Irfan
    Anis, Lubna
    Haider, Saida
    PAKISTAN VETERINARY JOURNAL, 2017, 37 (04) : 435 - 439
  • [8] Spontaneous arthritis and ankylosis in male DBA/1 mice: further evidence for a role of behavioral factors in "stress-induced arthritis"
    Braem, Kirsten
    Carter, Shea
    Lories, Rik J.
    BIOLOGICAL PROCEDURES ONLINE, 2012, 14
  • [9] Spontaneous arthritis and ankylosis in male DBA/1 mice: further evidence for a role of behavioral factors in “stress-induced arthritis”
    Kirsten Braem
    Shea Carter
    Rik J Lories
    Biological Procedures Online, 14
  • [10] Regulatory role of the cannabinoid CB2 receptor in stress- induced neuroinflammation in mice
    Zoppi, S.
    Madrigal, J. L.
    Caso, J. R.
    Garcia-Gutierrez, M. S.
    Manzanares, J.
    Leza, J. C.
    Garcia-Bueno, B.
    BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (11) : 2814 - 2826